Ophthalmology Drugs and Devices Market Size, Share, growth, Trends

The rising number of geriatric population is the major factor accelerating the growth of the market. Furthermore, increasing prevalence of diabetes, increasing investment in research and development, rising eye disorders, presence of strong emerging pipeline drugs are also expected to drive the growth of the ophthalmology drugs and devices. However, lack of health insurance amongst population especially within the developing countries restrains the ophthalmology drugs and devices, whereas, lack of insurance covering all types of IOLs or contact lens in developed countries will challenge the growth of ophthalmology drugs and devices.

In addition, increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration will create ample opportunities for the ophthalmology drugs and devices.